Arkolith/Insider Trading/CKPT/Form 4

Rosenwald Lindsay A MD

DirectorCheckpoint Therapeutics, Inc. (CKPT) · full profile →Form 4 · filed May 30, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 30, 2025Tender(U)207K——0
May 29, 2025Grant(A)50K$1.29$65K207K
May 28, 2025Grant(A)12K—$0157K

Transaction Codes

U
See SEC Form 4 code table
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-054692) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML